| Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast. | |
| | |
MedLine Citation:
|
PMID: 18213475 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Loss of the chromosomal material at 16q is the most frequent genetic event in invasive and in situ (LCIS) lobular carcinoma of the breast. However, the smallest region of overlap at 16q is not restricted to just the CDH1 locus harbouring E-cadherin, suggesting that neighbouring genes might be involved in the development and progression of these tumours. Potential novel tumour suppressor genes (TSG) at 16q include CCCTC-binding factor (CTCF), Decreased Expression in Renal and Prostate Cancer (DERPC) and Dipeptidase 1 (DPEP1). The aim of this study is to assess the expression of these genes in LCIS and compare them with normal breast, using CDH1 as a control, in order to evaluate their role as TSGs. METHODS: Cells from LCIS cases and normal breast lobules were microdissected and expression of target genes were quantified using real-time PCR. In addition, immunohistochemistry (IHC) for E-cadherin and CTCF was performed on paraffin processed LCIS (n=49) and normal breast cases. RESULTS: All LCIS showed negative expression of E-cadherin. Similar to CDH1, CTCF and DPEP1 gene expression was significantly lower in LCIS cases compared with normal cases (P<0.05). CTCF IHC expression showed significant reduction in LCIS compared to normal parenchymal cells. However, there was no difference in expression of DERPC between LCIS and normal breast tissue. CONCLUSIONS: In addition to CDH1, loss of CTCF and DPEP1 gene expression suggest they are possible TSG in breast cancer and may, similar to CDH1, be potentially utilised as markers of predisposition of women diagnosed with LCIS. |
| | |
Authors:
|
Andrew R Green; Sophie Krivinskas; Peter Young; Emad A Rakha; E Claire Paish; Desmond G Powe; Ian O Ellis |
Related Documents
:
|
7683425 - Identification of a colon mucosa gene that is down-regulated in colon adenomas and aden... 20371465 - Why most gene expression signatures of tumors have not been useful in the clinic. 9598315 - The human rox gene: genomic structure and mutation analysis in human breast tumors. 18218085 - The combined immunodetection of ap-2alpha and yy1 transcription factors is associated w... 20360305 - Transcriptome analysis and molecular signature of human retinal pigment epithelium. 20579805 - Hunting for robust gene signature from cancer profiling data: sources of variability, d... |
Publication Detail:
|
Type: Journal Article Date: 2008-01-23 |
Journal Detail:
|
Title: Breast cancer research and treatment Volume: 113 ISSN: 1573-7217 ISO Abbreviation: Breast Cancer Res. Treat. Publication Date: 2009 Jan |
Date Detail:
|
Created Date: 2008-12-22 Completed Date: 2009-02-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8111104 Medline TA: Breast Cancer Res Treat Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 59-66 Citation Subset: IM |
Affiliation:
|
Division of Pathology, School of Molecular Medical Sciences, University of Nottingham and Nottingham University Hospitals NHS Trust, Queen's Medical Centre, Nottingham, UK NG7 2UH. andrew.green@nottingham.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Breast Neoplasms / genetics* Carcinoma in Situ / genetics* Carcinoma, Lobular / genetics* Chromosome Deletion Chromosome Mapping* Chromosomes, Human, Pair 16* DNA Primers DNA-Binding Proteins / genetics Female Gene Expression Regulation, Neoplastic Humans Immunohistochemistry Middle Aged Oligonucleotide Array Sequence Analysis RNA, Neoplasm / genetics, isolation & purification RNA, Ribosomal, 18S / genetics Repressor Proteins / genetics Reverse Transcriptase Polymerase Chain Reaction |
| Chemical | |
Reg. No./Substance:
|
0/CCCTC-binding factor; 0/DNA Primers; 0/DNA-Binding Proteins; 0/RNA, Neoplasm; 0/RNA, Ribosomal, 18S; 0/Repressor Proteins |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Ten years after the Dutch public health campaign on folic acid: the continuing challenge.
Next Document: Towards an optimized platform for the detection, enrichment, and semi-quantitation circulating tumor...